CEL Celadon Pharmaceuticals Plc

61.00

1.50 (2.52%)

22 Jul 2024 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Celadon Pharmaceuticals Plc	LSE:CEL	London	Ordinary Share	GB00BDQYGP38	ORD 1P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	1.50	2.52%	61.00	57.00	65.00	61.00	59.50	59.50	12,246	14:00:11

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
Investment Advice	149k	-7.14M	-0.1082	-5.64	39.26M

Stmnt re Press Comment

10/12/2001 10:53am

UK Regulatory

RNS Number:4141O
Celsis International PLC
10 December 2001

             Celsis International plc ("Celsis" or the "Company")

Following today's press speculation concerning the appointment of advisers to
sell the Company, the Board of Celsis confirms that it has decided to pursue a
review of strategic options, including a possible sale of the Company or a
division, and that PwC Corporate Finance and WestLB Panmure are assisting the
Company in carrying out this review. This review is at a very early stage.

A further announcement will be made in due course.

10 December 2001

Celsis International Plc                            01223 426 008
Jay LeCoque
Peter Grant

PwC Corporate Finance                               020 7583 5000
Neal Ransome
Mark Butler

WestLB Panmure                                      020 7020 4000
Ron Oppenshaw